Shuang-Mei Zhu

miR-483–5p promotes esophageal cancer progression by targeting KCNQ1

Yong Chen, Han-Ying Wang, Shuang-Mei Zhu et al. · Biochemical and Biophysical Research Communications · 2020 · 22 citations

Esophageal Cancer, Cancer Cell Biology, Tumor Suppressor +5

Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review

Weimin Mao, Xiaoling Xu, Wei Chen et al. · OncoTargets and Therapy · 2016 · 16 citations · Full text

p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up

Xiaoling Xu, Weihui Zheng, Kaiyi Tao et al. · Medical Oncology · 2014 · 15 citations

Tumor Biology, Surgical Oncology, Esophageal Cancer +10

The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience

Xiaoling Xu, Weihui Zheng, Shuang-Mei Zhu et al. · PLoS ONE · 2015 · 15 citations · Full text

Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma

Shuang-Mei Zhu, Yong Chen, Hong Ye et al. · Annals of Hepatology · 2022 · 15 citations · Full text